Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T Cells in Patients With Metastatic or Recurrent Melanoma

NCT03997474 is registered in ClinicalTrials.gov with Achilles Therapeutics UK Limited as lead sponsor.

NCT NCT03997474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03997474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T Cells in Patients With Metastatic or Recurrent Melanoma
Lead sponsor
Achilles Therapeutics UK Limited
Phase
Phase 1/2
Overall status
Terminated
Start date
August 15, 2019
Completion date
September 3, 2024
Enrollment
13 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma